Insider trade

Medicus Pharma (MDCX): CFO received 29K shares

Carolyn F. Bonner, CFO at Medicus Pharma, reported a grant / award of 29K shares.

29K
Shares · @ $1.72
Traded
Nov 13, 2026
Filed
Nov 17, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 11, 2026Company filing · Form 8-K · Agreement endedEnded an important agreement
  2. Oct 12, 2026Company filing · Form 8-K · Shareholder rights, Bylaws or charterChanged the rights of its shareholders, and changed its bylaws, charter or fiscal year
  3. Oct 16, 20265% stakeMelani Kenneth R. reported a passive stake (13G) of 3.6%
  4. Oct 20, 2026Company filing · Form 8-K · Listing notice, Other newsReceived a notice from its stock exchange, and reported other company news“On October 23, 2026, Medicus Pharma Ltd. (the "Company") received written notice (the "Compliance Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it had regained compliance with the $1.00 minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement"), and that the matter was…”

What came next

  1. Nov 16, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 2 more items)
  2. Nov 17, 20265% stakeBOKHARI, RAZA filed an activist stake (13D) of 19.1%
  3. Nov 19, 2026Company filing · Form 8-K · Listing notice, Reg FDReceived a notice from its stock exchange, and shared information with investors (and 1 more item)“As previously disclosed in the Current Report on Form 8-K filed by Medicus Pharma Ltd. (the "Company") with the Securities and Exchange Commission (the "SEC") on May 27, 2026, on May 20, 2026, the Company received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that its Market Value of Listed Securities had been below $35 million for the…”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Medicus Pharma

For Medicus Pharma, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDCX page.

How this filing works

Explore the data

Common questions

Which Medicus Pharma (MDCX) insider traded, and how much?

Carolyn F. Bonner, CFO at Medicus Pharma, reported a grant / award of 29K shares. At $1.72.

When did it happen, and when was it made public?

Traded: Nov 13, 2026. Filed: Nov 17, 2026. That is 4 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Medicus Pharma recently?

For Medicus Pharma, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the MDCX page.

Does this mean MDCX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Medicus Pharma

Everything OQRO holds on this company is on its MDCX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data